Comment on Kang et al.'s "Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis"

Am J Nephrol. 2023 Aug 17:1-2. doi: 10.1159/000533172. Online ahead of print.NO ABSTRACTPMID:37591228 | DOI:10.1159/000533172

Source: American Journal of Nephrology - August 17, 2023 Category: Urology & Nephrology Authors: Shih-Wei Lai Source Type: research